Latest news with #Technion
Yahoo
04-07-2025
- Business
- Yahoo
Qedma raises $26m in Series A funding
Qedma, an Israel-based company specialising in solutions for quantum computing errors, has secured $26m (NIS87bn) in Series A funding, with IBM among the new investors. The investment round was led by Glilot Capital Partners, alongside Korean Investment Partners and existing supporters including TPY Capital. Qedma was founded in 2020 following collaborative discussions among Technion physicist Netanel Lindner, Asif Sinay, and Hebrew University professor Dorit Aharonov. The trio came together over insights into noise patterns in quantum devices and error correction strategies, establishing a firm focused on integrating theoretical and practical solutions to quantum errors. Qedma aims to tackle the critical issue of quantum noise resilience and plans to demonstrate quantum advantage through collaborations with various companies and research institutions. According to the start-up, quantum computing faces significant challenges due to errors that arise as systems grow in size and complexity. Existing error correction techniques, though theoretically effective, require substantial overhead, which often involve up to 1,000 qubits to correct errors for a single qubit. Qedma's software is engineered to accelerate progress towards practical quantum computing by reducing these errors. It is said to enhance hardware performance and enable larger-scale computations than currently possible. The company's solution works by executing a protocol when a user requests a quantum algorithm. This protocol identifies the noise characteristics unique to each device and adjusts the algorithm to suppress specific types of errors. Remaining errors are mitigated through post-processing methods. As technology advances, Qedma aims to integrate proprietary error correction techniques combined with mitigation strategies for increased reliability. Qedma CEO and co-founder Sinay said: 'While the industry is making massive investments in quantum computing infrastructure and scaling the number of qubits, our platform-agnostic approach allows us to extract maximum value from existing hardware across all quantum computing architectures. 'By accelerating the timeline to practical quantum computing, we're establishing a fundamental foundation that will become even more crucial as quantum systems scale." In September 2024, Qedma joined forces with IBM to offer its Quantum Error Suppression and Error Mitigation (QESEM) software via the latter's Qiskit Functions platform. The collaboration with IBM focuses on addressing noise-induced errors in quantum operations. These errors present a major challenge in achieving Quantum Advantage, where quantum computers surpass classical systems in practical applications. By integrating QESEM, quantum developers, data scientists, and computational scientists are expected to interact with quantum computers as seamlessly as they do with classical systems. This approach allows for the efficient execution of quantum algorithms without the need for extensive qubit overheads, said Qedma. IBM venture capital global head Emily Fontaine said: "Qedma continues to make meaningful contributions that are progressing the quantum computing space at a pivotal time in the industry. "We're excited to see their next chapter as they scale their impact, working towards their mission to advance quantum computation and provide error reduction software solutions to the quantum ecosystem." "Qedma raises $26m in Series A funding" was originally created and published by Verdict, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Irish Independent
26-06-2025
- Politics
- Irish Independent
Protestors in Connemara call for University of Galway to end ties with Israeli institution
The third level institute confirmed that the research project with Technion is currently under review Today at 04:52 Pro-Palestine protestors have promised further action following a demonstration against University of Galway's ties to an Israeli institution in Connemara. A crowd of 100 people gathered outside Ionad an Acadaimh in An Cheathrú Rua on Wednesday as key university stakeholders met for a scheduled meeting of Údarás na hOllscoile. An initial meeting of the protestors took place at University of Galway's quadrangle at midday before the demonstrators boarded a bus to An Cheathrú Rua. The protest was a follow-up to an initial demonstration in February against the university's ties with Israeli education institute Technion, which is participating in a €1.5million research project that is coordinated by the University of Galway. A spokesperson for the protest said Technion is involved in the study and development of AI and weapons used in Gaza and the West Bank. The demonstration was organised by the university's Palestine Solidarity Society and SIPTU – with both groups calling for University of Galway to sever all ties with Israeli institutions. In a short statement released to the Irish Independent, the University of Galway confirmed that the research project involving Technion remains under review. One of the protest's organisers and spokesperson for the Palestine Solidarity Society Emmet O'Reilly said that the protest is the culmination of 'two years' of unfulfilled promises. 'We have been doing this for two years and we've been speaking to them at different times, believing that they'll fulfil their promises and then seeing that they won't and having different protests through campus. 'But now ourselves and SIPTU are going to come together and organise more direct action because the talking, the meetings and the good faith are over – it clearly hasn't worked.' Mr O'Reilly says there is a 'huge want' amongst the student population for Palestine protestors to take more action against the university. 'No more arbitrary marches, meetings or press conferences and more actual action to force the hand of the university. Bring them in by the heels to the desk to finalise the breakage of the Technion deal itself with no more strings attached.'
&w=3840&q=100)
Business Standard
05-06-2025
- Health
- Business Standard
Israel's RedC wants to turn donor cells into $50 shelf-ready blood
Although RedC has already produced small quantities of blood using this process, the real test will be whether it can scale up production, bring down costs, and secure regulatory clearances Surajeet Das Gupta New Delhi Listen to This Article In the next five to six years, you might be able to buy laboratory (lab)-grown blood off the shelf for just $50 a unit, compatible with all blood types. An Israel-based company, RedC Biotech, is working towards that goal. It is developing a process that reprogrammes blood from universal donors (O-negative) by deactivating genes in the white blood cells, converting them into stem cells. These are then harvested and multiplied in large bioreactors capable of producing 2,000 litres of red blood cells, using technology developed by the Technion — Israel Institute of Technology. Although RedC has already produced small quantities
Hans India
08-05-2025
- Health
- Hans India
Researchers find genetic fingerprints to predict efficacy of immunotherapy
Israeli researchers have identified a genetic "fingerprint" that helps predict the effectiveness of immunotherapy treatments, according to a study. The study, by the Israel Institute of Technology (Technion), stated that the discovery would help improve the personalisation of immunotherapy treatments, Xinhua news agency reported. Immunotherapy is considered to be one of the greatest revolutions in cancer treatment. It enhances the immune system's ability to target and destroy cancer cells efficiently. However, a major challenge in immunotherapy is the unpredictability of patient responses. Some patients do not benefit and may experience side effects without significant improvement. Therefore, there is a need to identify biomarkers that can forecast the effectiveness of treatment based on the specific data of each patient. In their study, published in the journal Cell Genomics, the team examined the genetic characteristics of T-cell clones -- groups of multiplied immune T cells that specialise in targeting a specific threat once recognised -- and their influence on treatment success. To achieve the goal, the team conducted a large-scale meta-analysis using single-cell RNA sequencing and T-cell receptor sequencing data from cancer patients undergoing immunotherapy. It was found that although these T-cell clones are present in both responsive and non-responsive patients, those who respond to immunotherapy display a distinct genetic signature in their T-cell clones, and the treatment boosts their immune activity. Another major finding was that in non-responsive patients, some T-cell clones were simultaneously found both in the bloodstream and the tumour. To achieve a better immune response, it is crucial to activating T-cell clones located solely within the tumour, rather than those present in both the tumour and the bloodstream, the researchers said. They added that this discovery will enhance predictive capabilities and could lead to new treatment strategies that improve the effectiveness of immunotherapy.
Associated Press
24-03-2025
- Business
- Associated Press
Setting Sail from Shenzhen: GRABO LIMITED Expands Global Reach with Groundbreaking Products
HongKong, Chia, March 24, 2025 -- GRABO LIMITED, a leading innovator in the global power tools and technology sector, is making waves in international markets with its cutting-edge electric suction cup technology. Based in Shenzhen, China—the heart of global hardware innovation—the company has expanded its influence by leveraging the city's robust manufacturing capabilities. Shenzhen: GRABO's Global Innovation Lab Shenzhen, known as the 'Silicon Valley of Hardware,' boasts the world's most comprehensive supply chain, from raw materials to manufacturing and city's advantages have allowed GRABO LIMITED to create innovative products that are now recognized worldwide. 'Shenzhen is a paradise for hardware entrepreneurs and a hub for global innovators,' said Nimrod Rotem, the founder of GRABO LIMITED. Today, his innovative products have reached markets worldwide, and Shenzhen has become his perfect testing ground for global expansion. Thanks to Shenzhen's manufacturing advantages, GRABO quickly gained international recognition, becoming a viral product in its industry. GRABO's success is a testament to the company's strategic approach to integrating innovative technology with China's advanced manufacturing ecosystem. From Heavy Lifting to Cultural Bridges Nimrod graduated from the Technion – Israel Institute of Technology, often referred to as the 'MIT of Israel.' Even as a university student in 2008, he was restless, founding his own company, Gizmo Maker, and making breakthroughs in defense, medical devices, and smart home technology. Yet, he always felt that the world was vast and that opportunities extended far beyond Israel. In 2013, Nimrod founded Nemo Power Tools, setting up production bases in Shenzhen and Huizhou, where he launched the world's first waterproof cordless power tool. This tool provided significant convenience for underwater workers and even attracted high-profile clients like NASA. However, Nimrod's innovations extend beyond product technology—they also bridge cultural exchanges. Having worked in Shenzhen for years, he has built deep friendships with his Chinese colleagues, learned to make dumplings, and experienced the charm of the Chinese New Year. To integrate better into the Chinese market, Nimrod embraced local business customs—engaging in 'tea-time business meetings,' which emphasize trust and relationship-building, in contrast to the fast-paced, direct meetings common in Western business culture. By embracing local business practices and cultivating strong relationships with Chinese enterprises, GRABO LIMITED is positioned to lead the way in global markets, bringing its breakthrough solutions to an ever-growing customer base. The Growth of an Brand: How Grabo brand Achieved Global Influence As GRABO LIMITED's products expand into international markets, the company focuses on refining product designs based on market feedback and continuously advancing its technological offerings. Nimrod believes that true innovation isn't just about technological advancements—it's about making life more convenient and efficient. By continuously improving product designs, GRABO has secured 67 patents and become as a leader in industries such as construction, renovation, and logistics. The GRABO electric suction cup, developed by the company's founder Nimrod Rotem, has revolutionized heavy lifting, making it a vital tool for professionals worldwide. Today, the GRABO brand has built a global distribution network of 150 partners, attracting attention from major corporations like Stanley Black & Decker and Chervon. This success is driven by a strong commitment to innovation, strategic collaborations, and leveraging the global manufacturing ecosystem in China. Expanding Globally from China As Chinese companies solidify their presence in global markets—especially in power tools and consumer electronics—China's share in these sectors has surpassed 30%. GRABO LIMITED is seizing this opportunity to expand globally. The CEO of GRABO LIMITED, Nimrod Rotem, chose to root himself in Shenzhen, recognizing the vast potential for innovation and growth. His vision for GRABO LIMITED has resulted in the creation of groundbreaking products and a successful international expansion strategy. A Future of Global Innovation With a focus on technological advancement and continuous product innovation, GRABO LIMITED is poised to further its influence worldwide. The company's journey is a powerful example of how collaboration between international entrepreneurs and Chinese enterprises can lead to remarkable global success. Nimrod Rotem's entrepreneurial journey is a legend of crossing borders—geographical, cultural, and industrial. His success exemplifies the openness and inclusiveness of Shenzhen. From Israel to China and beyond, Nimrod's journey of innovation is far from over. With technology as his driving force, he will continue to propel global innovation and create more inspiring chapters in his story. Contact Info: Name: Coffee N Email: Send Email
